title: Serum total antioxidant capacity in oral carcinoma patients.
abstract: BACKGROUND
  Oxidative stress is a major determinant in carcinogenesis and serum total antioxidant capacity (TAC) indirectly reflects the level of oxidative stress. Although oral cancer is the third most frequent cancer in Indian population, there are no standard noninvasive marker for early detection and monitoring therapeutic response in oral cancer patients.
  
  
  OBJECTIVE
  This study was carried out to investigate implications of serum TAC in oral cancer by evaluating pre- and post-operative levels in oral cancer patients.
  
  
  METHODS
  It was a prospective single blinded study.
  
  
  METHODS
  Serum TAC was measured using ferric-reducing antioxidant power assay. Pre- and post-operative values were estimated and compared in 30 oral cancer patients who underwent surgery.
  
  
  METHODS
  Paired t-test was used to compare pre- and post-operative values.
  
  
  RESULTS
  Compared to the normal value, both pre- and post-operative serum TAC were significantly low in oral cancer patients. However, there was no statistically significant difference between pre- and postoperative levels.
  
  
  CONCLUSIONS
  In this study, low mean serum TAC was detected in oral cancer patients. However, its diagnostic and prognostic significance in oral cancer needs further investigation.
authors.affiliation: Department of Otorhinolaryngology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.
authors.forename: K S
authors.initials: KS
authors.lastname: Rathan Shetty
authors.affiliation: Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.
authors.forename: Arunava
authors.initials: A
authors.lastname: Kali
authors.affiliation: Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India.
authors.forename: K S
authors.initials: KS
authors.lastname: Rachan Shetty
keywords: Cancer marker; oral cancer; squamous cell carcinoma; total antioxidant capacity
references.citation: Eur J Dent. 2010 Apr;4(2):202-7
references.pmid: 20396454
references.citation: Eur Rev Med Pharmacol Sci. 2012 Apr;16(4):530-2
references.pmid: 22696882
references.citation: Clin Sci (Lond). 2004 Jan;106(1):93-8
references.pmid: 12875648
references.citation: Int J Cancer. 2013 Sep 15;133(6):1447-51
references.pmid: 23444117
references.citation: Chang Gung Med J. 2011 Nov-Dec;34(6):607-11
references.pmid: 22196063
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Indian J Cancer. 2012 Apr-Jun;49(2):215-9
references.pmid: 23107973
references.citation: J Nutr. 2002 Feb;132(2):303-6
references.pmid: 11823595
references.citation: Cell Biochem Funct. 2007 Jul-Aug;25(4):377-82
references.pmid: 16447143
references.citation: Cancer. 2008 Jul 15;113(2):336-46
references.pmid: 18521898
references.citation: Asian Pac J Cancer Prev. 2006 Jan-Mar;7(1):108-12
references.pmid: 16629526
references.citation: Int J Cancer. 2012 Aug 15;131(4):E544-54
references.pmid: 22072493
references.citation: Oncology. 2011;80(5-6):382-9
references.pmid: 21829039
references.citation: Chang Gung Med J. 2011 Sep-Oct;34(5):449-60
references.pmid: 22035889
references.citation: Oncogene. 2002 Oct 21;21(48):7435-51
references.pmid: 12379884
references.citation: Adv Clin Exp Med. 2013 May-Jun;22(3):431-7
references.pmid: 23828685
references.citation: J Nat Sci Biol Med. 2013 Jan;4(1):122-5
references.pmid: 23633847
references.citation: Lancet Oncol. 2008 Jul;9(7):667-75
references.pmid: 18598931
references.citation: Indian J Med Sci. 2003 Sep;57(9):400-4
references.pmid: 14515030
references.citation: J Postgrad Med. 2001 Jul-Sep;47(3):171-6
references.pmid: 11832617